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持続糖濃度測定装置(CGMS)を用いた1型糖尿病患者
における重症無自覚低血糖のリスクの検討
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Background/Aim: Low blood glucose index (LBGI) , a predictor of hypoglycemia, is evaluated by self-
measurement of blood glucose (SMBG). We investigated whether LBGI from short-term continuous glucose moni-
tor (CGM) could also predict severe hypoglycemia (SH).
Subjects and Methods: Type 1 diabetic patients (n=250, 75 men) with HbA1c＜10 % who consented to using
a CGM were recruited. Twenty patients were treated with insulin pump and the rest with multiple daily injec-
tions of insulin. Blood glucose fluctuation index was compared between group A, with SH unawareness and group
B with SH awareness, and the correlation factors with LGBI was investigated.
Results: Group A, with a longer duration of diabetes than group B, displayed significantly higher J-index, av-
erage daily risk range (ADRR), mean of daily difference of blood glucose (MODD), and LBGI. Both LBGI and
MODD were independent risk factors for SH unawareness by multiple regression analysis (OR: 1.20, 1.04; p =
0.043, 0.002, respectively).
Discussion: The LBGI from CGM data can be predictive of SH. Even without SH, some patients in group B
displayed high LBGI values. MODD and ADRR in group A were also significantly lower than in group B. This
suggested that SH unawareness might occur in patients with larger daily and diurnal blood glucose variations.
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MAGE（mean amplitude of glucose excursion），
ADRR（average daily risk range，mg/dl），MODD
（mean of daily differences，mg/dl），LBGI，HBGI










male/female (n) 4/17 71/158 0.111＊
current age (yrs) 46±10 43±13 0.313
onset age (yrs) 20±10 24±14 0.286
duration of diabetes (yrs) 25±12 18±11 0.028
BMI (kg/m2) 22.2±2.5 23.2±3.2 0.205
CSII / MDI (n) 1/20 19/210 0.321＊
required Insulin dose (units/kg/day) 0.76±0.33 0.74±0.26 0.814
basal insulin dose (units/kg/day) 0.38±0.15 0.37±0.13 0.815
retinopathy stage (none/background/proliferative) 10/7/4 157/45/27 0.148＊
nephropathy stage (stage 1/2/3) 20/1/0 206/21/2 0.716＊
Group A are patients with severe unawareness hypoglycemia, and group B are patients without 
severe hypoglycemia.
＊Fisher’s exact probability test, mean±SD.
Table　2　Comparison of HbA1c and indices of blood glucose fluc-






HbA1c (%) 7.8±1.0 7.8±0.9 0.986
mean blood glucose (mg/dl) 168±30 155±35 0.053
%CV 43.7±9.3 44.8±22.7 0.753
J-index 59.7±18.7 51.2±22.8 0.039
M-value (mg/dl) 30.2±14.7 26.6±17.8 0.073
MAGE (mg/dl) 124±34 117±37 0.347
ADRR (mg/dl) 53.5±16.8 47.1±36.9 0.005
MODD (mg/dl) 79.4±22.1 68.3±21.2 0.020
LBGI 5.1±3.3 2.9±2.7 0.005
HBGI 8.0±3.9 7.8±4.9 0.76
Group A are patients with severe unawareness hypoglycemia, and group 
B are patients without severe hypoglycemia.
MAGE, mean amplitude of glucose excursion; ADRR, average daily risk 
range; MODD, mean of daily difference of blood glucose; LBGI, low blood 











カテゴリカル変数は Fisher’s exact probability test
を使用した．単相関は Pearson’s rank correlation
testを，無自覚低血糖予測因子の検討は多重ロジス
ティック回帰分析を用い，p＜0.05を統計学的有意と














Table　3　Comparison of HbA1c and indices of blood glucose fluc-
tuation between patients with severe hypoglycemia and without 





HbA1c (%) 7.4±1.4 7.5±1.1 0.777
mean blood glucose (mg/dl) 173±29 167±37 0.578
%CV 47.7±9.2 44.1±9.48 0.347
J-index 66.2±17.3 59.9±23.8 0.406
M-value (mg/dl) 36.0±12.4 32.6±17.6 0.531
MAGE (mg/dl) 144±38 130±35 0.359
ADRR (mg/dl) 65.6±6.6 54.0±15.8 0.003
MODD (mg/dl) 87.0±22.1 63.4±24.5 0.020
HBGI 6.8±2.3 4.9±4.1 0.110
Group A are patients with severe unawareness hypoglycemia, and group 
B are patients without severe hypoglycemia.
MAGE, mean amplitude of glucose excursion; ADRR, average daily risk 
range; MODD, mean of daily difference of blood glucose; LBGI, low blood 
glucose index; HBGI, Hugh blood glucose index.
Unpaired t-test, mean±SD.
Table　4　Single correlation analysis between LBGI 
and clinical characteristics, other indices of blood 
glucose fluctuation
R p
duration of diabetes 0.990 0.154
insulin dose (unit/kg/day) 0.112 0.092
HbA1c (%) 0.029 0.821
mean blood glucose (mg/dl) 0.152 0.019
SD －0.080 0.462
J-index (mg/dl) 0.169 0.009
%CV 0.042 0.527
M-value 0.192 0.003
MAGE (mg/dl) 0.156 0.017
ADRR 0.404 ＜0.001
MODD (mg/dl) －0.015 0.825
HBGI －0.460 ＜0.001
Group A are patients with severe unawareness hypoglyce-
mia, and group B are patients without severe hypoglyce-
mia.
MAGE, mean amplitude of glucose excursion; ADRR, aver-
age daily risk range; MODD, mean of daily difference of 
blood glucose; LBGI, low blood glucose index; HBGI, hugh 
blood glucose index.






































HbA1c (%) 1.02 0.69-1.43 0.8968
mean blood glucose (mg/dl) 1.00 0.99-1.02 0.1857
J-index 1.01 0.99-1.03 0.2293
MAGE (mg/dl) 1.00 0.99-1.02 0.4398
M-value (mg/dl) 1.01 0.99-1.02 0.3954
MODD (mg/dl) 1.03 1.00-1.05 0.0042
ADRR (mg/dl) 1.00 0.99-1.01 0.4609
LBGI 1.24 1.08-1.43 0.0037
HBGI 1.01 0.92-1.08 0.8795
Dependent variable: severe hypoglycemia without consciousness, mean±SD.
Table　6　Multiple logistic regression analysis
OR 95%CI p
LBGI 1.20 1.00 ～ 1.44 0.043
MODD 1.04 1.01 ～ 1.07 0.002
Dependent variable: severe hypoglycemia without aware-
ness.
Variable excluded the model: HbA1c, average blood glu-





























































(A): The CGM result of a patient who has severe unconscious hypoglycemia, with a high 
LBGI value of 10.2. The day-to-day variation is large, and the daily fluctuation of the blood 
glucose is also wide. (B): The result of a patient with low LBGI value of 0.12, who have not 
experienced severe unaware hypoglycemia. There is not much difference in day-to-day 
variation, and it can be seen that the daily fluctuation of daily glucose also remained from 
about 100 to over 200.
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